Cutaneous Toxicities of Molecular Targeted Therapies

Antineoplastic targeted therapies, such as EGFR inhibitors, tyrosine kinase inhibitors and BRAF inhibitors, frequently lead to systemic and cutaneous side effects, significantly affecting patient’s quality of life. Patients with new targeted therapies have an increased risk of developing skin reacti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Maedica (Bucur)
Asıl Yazarlar: STANCULEANU, Dana Lucia, ZOB, Daniela, TOMA, Oana Catalina, GEORGESCU, Bogdan, PAPAGHEORGHE, Laura, MIHAILA, Raluca Ioana
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: EDITORIAL POINT OF VIEW 2017
Konular:
State of the Art
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5574072/
https://ncbi.nlm.nih.gov/pubmed/28878837
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller